Variability in telavancin cross-reactivity among vancomycin immunoassays.

about

Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Comparison of a high-performance liquid chromatography method for quantification of carbamazepine with chemiluminescent microparticle immunoassay.

P2860

Q33438834-25A7D71A-E12F-4887-AEDB-ADA6B7E6A308 Q35798075-3D2139A0-6A54-4373-B75E-8AFB8D9721EA

P2860

Variability in telavancin cross-reactivity among vancomycin immunoassays.

Item

http://www.wikidata.org/entity/Q42140130

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@en

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@nl

type

Item

label

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@en

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@nl

prefLabel

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@en

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@nl

P1476

Variability in telavancin cross-reactivity among vancomycin immunoassays.

@en

P2093

Douglas Clark

http://www.w3.org/2001/XMLSchema#string

Keith A Rodvold

http://www.w3.org/2001/XMLSchema#string

Kevin W McConeghy

http://www.w3.org/2001/XMLSchema#string

Philip Worboys

http://www.w3.org/2001/XMLSchema#string

Siyun Liao

http://www.w3.org/2001/XMLSchema#string

Steven L Barriere

http://www.w3.org/2001/XMLSchema#string

P2860

Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease.

Telavancin pharmacokinetics and pharmacodynamics in patients with complicated skin and skin structure infections and various degrees of renal function.

Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.

Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteers

Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424).

P304

7093-7097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03785-14

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265691693

http://www.w3.org/2001/XMLSchema#string

P698

25223996

http://www.w3.org/2001/XMLSchema#string

P932

4249549

http://www.w3.org/2001/XMLSchema#string

Variability in telavancin cross-reactivity among vancomycin immunoassays.

about

P2860

P2860

Variability in telavancin cross-reactivity among vancomycin immunoassays.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932